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Key points
• Interface selection is mainly influenced by the patient’s face shape, mouth/nose breathing 
pattern, nasal pathology, experience of the staff, patient choice and equipment availability. 
Interfaces covering the mouth and nose are usually the first choice for acute NIV.
• Compatibility of the chosen interface with the ventilator circuitry should be checked and the 
exhalation port identified before NIV is started.
• Large air leaks affect the efficacy of NIV and should be avoided, whereas small air leaks can 
be compensated for by ventilators designed for NIV and are usually tolerated if they do not 
irritate the patient or disturb sleep.
• Routine assessment of the skin and risk of pressure ulcers, regular pressure relief and 
skin-protective strategies should be included in the routine application of NIV to reduce 
discomfort and the occurrence of soft tissue damage.
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How to avoid interface
problems in acute noninvasive
ventilation
Summary
Noninvasive ventilation (NIV) applied via different interfaces is increasingly used
in the treatment of acute respiratory failure. One of the key factors determining
the success of NIV is the choice of interface. Interface selection, fitting and
handling can be challenging as NIV application can be complicated by
discomfort, air leaks, skin damage or conjunctivitis. The aim of this article is
to provide practical information on interface choice, technical aspects of mask
fitting and prevention of mask-related problems during the acute delivery of NIV.
Educational aims
N To help the reader to recognise the different features of interfaces and to discuss
common interface-related problems
N To provide practical recommendations to facilitate the choice and application of
interfaces in order to reduce complications
The use of noninvasive ventilation (NIV) has
grown continuously over the past two dec-
ades. It has become a standard of care in the
treatment of many forms of acute respiratory
failure (ARF) and is now frequently applied in
intensive care units (ICUs), emergency
departments, post-surgical recovery rooms,
step-down units and respiratory wards [1–4].
Despite the overall success of the treatment
modality, NIV failure rates still range between
18% and 40% in the acute setting [1, 3, 5–7].
Primary failure of NIV reflects failure of
uptake of the technique and control of
respiratory failure; secondary failure is seen
when respiratory failure progresses despite
optimal NIV use.
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Patient selection, underlying pathology,
the severity of ARF, expertise with NIV and
interface tolerance all have a major impact on
the success or failure of NIV. Interface-related
problems such as air leaks, skin lesions or
discomfort are still common reasons for poor
adaptation to NIV and NIV failure [8–10].
They can often be addressed successfully with
basic knowledge of the principles of mask
fitting and handling.
The purpose of this article is to provide an
overview of strategies to anticipate, prevent and
manage interface-related problems in acute NIV.
Interface selection
A greater variety of different interface types,
styles and materials have been developed by
device manufacturers in recent years. This
allows a suitable interface to be found for
nearly every patient in most situations, but
having to deal with many different interfaces
and be able to select the most appropriate
one can be challenging for clinical staff. There
are six main classes of interfaces that are
commercially available in various sizes, all of
which have their advantages and disadvan-
tages (table 1). Custom made masks are
another option, but in the acute setting with
critically ill patients, there is usually not
enough time to fabricate these.
Interface selection is mainly influenced by
the patient’s individual characteristics (i.e.
facial anatomy, breathing pattern and indi-
vidual level of comfort) and clinical effective-
ness, but the experience of the staff,
equipment availability and economic aspects
are also relevant. In the few studies compar-
ing different types of interfaces in acute NIV,
the improvements in respiratory parameters,
i.e. dyspnoea, respiratory rate and arterial
blood gases, were usually similar and there is
no strong scientific evidence that one type of
mask is necessarily or consistently better than
others in terms of clinical efficiency. However,
patients in ARF often mouth-breathe and,
even if they can be started on a nasal mask, a
switch to an alternative interface covering the
nose and mouth is necessary in many
patients if mouth air leaks occur [11, 12]. In
clinical practice the most common initial
interface to treat ARF with NIV is, therefore,
an oronasal mask. This was reflected in the
results of a large web-based survey in Europe
and North America, with oronasal masks
(70%) being the first choice followed by total
face masks, nasal masks and helmets [13].
Oronasal
mask
Total face
mask
Nasal
mask
Nasal
prongs
Mouth
pieces
Helmet
Acute setting
Use outside HDU/ICU
High level of noise
High gas flow required
Chance of eye irritation
Speaking is easier
Less claustrophobic
More likely to have leaks
in the acute setting
Coughing and
expectoration is easier
Useful for prominent
facial anatomy
No pressure on the 
nasal bridge
Nasal patency required
Figure 1
Different interface types. HDU: high dependency unit. Closed circles: applicable to the interface; open circles: an
alternative, but less common or less frequent option.
Table 1
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The ability to try different mask types and
sizes quickly may enhance tolerance as
patients who do not adapt well to one type
of mask may comply with another. Having a
number of different mask types and sizes
attached to the NIV ventilator can, therefore,
be advantageous, although financial con-
straints may limit those available. Most
masks come with fitting gauges to avoid
selection of a mask that is too large or too
small and clinicians are encouraged to use
them to reduce complications. The mask
should not encroach on the corners of the
eyes or lips. Changing the interface can
reduce NIV failure, and is always worth trying
if large leaks are seen and demonstrated on
ventilator software or the type of interface is
not well tolerated by the patient, but experi-
menting with interfaces should not delay
intubation in a severely ill patient if NIV is
clearly failing. When switching to a different
mask, trigger sensitivity, pressurisation level,
and compatibility with the circuitry must be
checked.
In the long-term setting, nasal masks are
rated to be more comfortable than other
mask types [14] and cause skin problems less
often. If the patient is stable and there are no
major mouth air leaks, it may be reasonable
to swap to a nasal mask or nasal prongs. In
addition, patients in the post-acute setting
can sometimes be encouraged to continue
NIV by switching to a less claustrophobic
interface type.
Carbon dioxide rebreathing:
dead space and ventilator
circuits
Depending on the ventilator and circuit used,
NIV can be applied either via an open single-
limb circuit or a closed double-limb circuit.
An open single-limb circuit requires a vented
mask with a built-in exhalation port or a
nonvented mask and an additional exhalation
valve in the circuit to allow carbon dioxide
(CO2) removal. A closed double-limb circuit
is used with a nonvented mask and has an
exhalation port or filter for CO2 removal
within the system. It is essential to be aware
of which circuit is used when the mask is
chosen. The wrong combination, for example
a nonvented mask in an open single-limb
system and no exhalation port in the system,
can be fatal. Also, an exhalation port should
never be obstructed intentionally (e.g. taping
up the holes in the mask) to reduce leakage.
Different colours on the mask or the mask
elbow, with a blue colour representing non-
vented masks and a clear entrainment elbow
for vented models (fig. 1), can give guidance,
but it is not always a guarantee. For safe
treatment, it is important to locate the
exhalation port, assure its patency and check
compatibility of the circuit and interface prior
to the start of NIV.
The interface itself adds an additional
dead space to the system, which can increase
CO2 rebreathing. Bench studies have sug-
gested that CO2 rebreathing increases with
interfaces that have a higher internal volume
and decreases with a built-in exhalation port
[15]. The in vivo effect is only small and, with
the exception of the helmet, facial masks are
usually interchangeable [16].
Initiation of NIV
The first few hours of acute NIV are extremely
important, and time spent fitting the mask
and building the patient’s confidence is well
invested. Having a mask strapped immedi-
ately over the face can be very frightening for
a breathless patient in ARF, particularly if the
person is naı¨ve to NIV. A careful explanation
of what will happen and why NIV is used as
well as a description of the sensation the
Figure 1
A vented mask with a clear elbow, grey adapter and integrated exhalation port on the
left for single limb circuits. A nonvented mask with a blue elbow for dual limb systems is
shown on the right. Masks manufactured by ResMed Ltd. (Abingdon, UK).
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patient is likely to experience can help to
facilitate the treatment. Initiating NIV with
lower pressures while holding the mask or
having the patient hold the mask in place and
not attaching the straps until the patient is
ready to tolerate it can also help the patient to
acclimatise. Once the patient is able to
tolerate the mask, it can be secured with the
head straps.
Prevention and
management of mask-
related side-effects
At this point, the clinician who fits the mask
has to achieve a good mask seal while
providing the maximal possible comfort and
preventing mask-related complications.
Initially reducing air leaks is the major goal
of the mask fitting, but the longer the
treatment lasts, the more likely it is that
complications, including facial skin erythema,
skin breakdown, rash, conjunctivitis or dry-
ness of the mucosa, occur.
Air leaks
Intentional air leaks are incorporated into the
design of most NIV circuits and are necessary
for CO2 removal, but unintentional leaks
around the edge of the interface or through
the mouth can cause problems. Large air
leaks interfere with the effectiveness of the
treatment, while small air leaks can irritate
the patient, cause conjunctivitis or create
noise.
To provide adequate ventilation during
treatment with NIV, it is important to
maintain the pressure gradient from the
ventilator through the tubing, and from the
mask to the patient’s pharynx and sub-
sequent airways. Large air leaks can cause a
significant drop in the delivered intra-alveolar
pressure, reduce tidal volume and lead to
patient–ventilator asynchrony by affecting
trigger functions. All this contributes to
ineffective treatment, which is associated
with NIV failure [17]. Therefore, large air leaks
have to be minimised during NIV. Ventilators
designed for NIV can compensate for smaller
air leaks to a variable extent [18] and a small
amount of air leakage can be accepted as
long as the leak does not disturb the patient.
Besides using an appropriate interface
type, with the correct size and headgear, there
are several other interventions to reduce air
leaks. The most obvious, but least comfort-
able, solution seems to be further tightening
of the head straps. Sometimes, loosening the
head straps or temporarily lifting the mask
from the face and replacing it can have an
equivalent or better effect without causing
more pressure on the patient’s face. For
example, masks that incorporate double
spring air-filled cushions will fit and seal
better if the cushions are filled with air and
not tightly pressed against the face. Different
types of mask cushions, for example hydrogel
or foam cushions, are also available and
changing the cushion can sometimes
improve mask fit. In addition, mask support
rings, thin silicone or cotton comfort flaps,
mask liners, hydrogen or foam seals can be
tried. If the patient’s chin keeps dropping,
masks with a special under-chin support are a
useful alternative option.
With the use of nasal masks or nasal
prongs, air leaks through the mouth can
become problematic. Although the use of
chinstraps or mouth taping have been
suggested, changing to a mask type that
covers mouth and nose is usually the
recommended strategy in ARF. Chinstraps
can successfully reduce air leaks via the
mouth in selected patients in the chronic
setting [19], but they are not always tolerated
and there is little evidence to support their
use in ARF. Also, chinstraps can cause
discomfort, jaw or tooth pain and their use
should not be used to prolong an ineffective
treatment. Mouth taping has been shown to
decrease air leak from the mouth in a
physiological study in the chronic setting
[20], but it cannot be recommended in ARF
for obvious safety reasons.
If a disturbing air leak cannot be con-
trolled by other means and a change to a
different interface type is not possible, a small
reduction of peak inspiratory pressure or
switching from a volume-controlled to a
pressure-targeted mode of ventilation can
be tried. Conversely, increasing the pressure
with pressure-targeted ventilation or tidal
volume with volume-targeted ventilation can
improve minute ventilation despite the higher
leakage [21], as long as the patient tolerates
such a strategy. The additional volume will
add to the leakage, but nevertheless can
increase minute ventilation.
Interface problems in acute noninvasive ventilation
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Eye irritation
Smaller air leaks near the eyes can cause
irritation or conjunctivitis if they are not
noticed. Assessing for small air leaks by
placing the back of the hand over the area,
and asking the patient about eye irritation
routinely throughout the treatment and every
time the mask is fitted, can help to prevent
this complication. Artificial tears can be
applied if the eyes are affected.
Noise
If air leaks create noise, the mask should be
refitted and a lining can be added to seal it.
There is no problem with air leaks with the
helmet interface, but the high-flow system
creates a higher level of noise within the
device than other interfaces and providing ear
plugs for the patients can be helpful.
Mask pressure
A certain amount of pressure is usually
needed to keep the NIV mask in place and
seal it, but an excessively tight fit is
unnecessary. Too much pressure on the face
causes discomfort, contributes to skin
lesions, and can endanger tolerance and
success of NIV.
One of the most unpleasant and painful
iatrogenic interface-related complications in
NIV is facial pressure ulcers. These are seen
on areas of high pressure, mainly on the nasal
bridge, but can develop at any place where
the mask or headgear has contact with the
skin (fig. 2). The reported occurrence rate in
ARF varies depending on timing of the study,
patient population, masks and skin protective
strategies used. Reports from earlier NIV
trials range from 5% to 56% [22, 23]; although
improvements in mask design have helped to
decrease the problem, more recent reports
still range from 3% to 87% [24–27]. This can
be partly explained by the expansion of NIV
indications towards more severely ill patients
at risk for pressure ulcers, ventilation with
higher inspiratory pressures that promote air
leaks, and the constantly increasing number
of NIV services with initially less experienced
staff and only a small selection of masks
available. The fact that the respiratory support
needed by the patient is naturally rated more
of a priority by medical staff than the local
skincare also contributes to the persistence of
the problem.
Interface-related pressure ulcers are
medical-device related pressure ulcers and
the longer treatment lasts the more likely they
are to develop. A number of patient-depend-
ent risk factors facilitate their occurrence
(table 2), but the literature shows that the
main cause for these pressure ulcers is often
associated with a lack of understanding of
how and how often to remove devices and
inspect the skin, and how to ensure the
device fits appropriately to minimise friction
and pressure [28]. Most of the patient-
dependent risk factors cannot be changed,
but if mask fitting, regular assessment and
skin protection are considered from the
beginning of therapy and adapted to the
individual patient’s needs, skin breakdown
can be avoided or at least reduced in many
cases.
It is important to identify patients at risk
of developing pressure ulcers from the
interface so that preventive strategies can
be initiated early. An initial assessment of
every patient receiving NIV should include
examination of skin integrity on the face and
around the head, in areas where the skin
comes into contact with the headgear, and
the common risk factors for healthcare
and device-related pressure ulcers. The skin
should be reassessed at least once per
nursing shift and ideally every time the mask
is removed.
The most important strategy in the
prevention of pressure ulcers is to keep the
pressure applied to the skin as low as
possible. Admittedly, it can be challenging
to find the ideal strap tension and mask fit
b)a)
Figure 2
a) Grade III pressure ulcer on the nasal bridge and b) grade II pressure ulcers on the
cheeks.
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that allows for both a good seal and low
pressure on the skin. A physiological study on
a head model showed that a pressure of the
mask against the face about 2–3 cmH2O
higher than the peak inspiratory airway
pressure is enough to prevent extensive air
leaks [29]. Unfortunately, the pressure on the
face cannot be measured objectively in
everyday care or in every mask type and it
does not give information on single points of
high pressure, for example the nasal bridge.
Therefore, the clinicians who fit the mask
have to be guided by the patient’s feedback
and their experience. The correct size of mask
and headgear with a higher number of
attachment points will help to distribute the
pressure more evenly around the circumfer-
ence of the mask. Tightening the mask straps
until the air leak is only just controlled,
purposely leaving a very small air leak or to
allow enough space to pass at least two
fingers underneath the head strap (fig. 3)
[30], can also help to avoid an over-tightening
of the head straps.
Skin-protective strategies include ensur-
ing the skin is clean and dry, as well as
Table 2 Risk factors for the development of interface-related pressure ulcers in NIV
General risks
Sensory impairment
Acute illness
Chronic illness
Hypoxia or very low blood pressure
Extremes of age
Low level of consciousness
Psychological status
Vascular disease
Malnutrition/dehydration
Chronic skin condition
History of previous pressure damage
Medication (e.g. analgesia, chronic steroid therapy, cytotoxins)
Extrinsic factors
Closely fitting headgear and over-tightened straps
Poorly fitted masks and headgear (i.e. too big or too small, too old or wrong style)
Mechanical forces: pressure, shear or friction from the interface
Allergy to the cushion
Other factors
Skin damage: dry, flaky, excoriated, discoloured or macerated skin
Oedema
Shape and size of nose/face
Time period that mask pressure is applied
Inability to self-manage the mask
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regular pressure relief, use of special mask
cushions, and application of dressings to the
skin to redistribute pressure and reduce
friction. For patients with very prominent
anatomy or at higher risk of developing
pressure ulcers, masks with softer cushions
(e.g. hydrogel cushions or double spring air-
filled cushions, or a combination of both) can
be used. An adjustable forehead spacer can
also help to distribute the pressure more
evenly on the face and reduce it on the bridge
of the nose. For difficult cases, the choice of a
more costly, but very comfortable mask, is
appropriate and can be cost-effective if it
avoids intubation.
Giving the skin regular breaks from
interface pressure, ideally every 2–4 h, is
important to reduce pressure effects and
allows for inspection of the skin underneath
the mask. If this is not done, very severe skin
and tissue damage can occur as demon-
strated in a case report of a patient in whom
the mask was not removed for .90 consecu-
tive hours [31]. Some patients deteriorate
rapidly when the mask is removed, but they
can be changed to an alternative interface to
relieve pressure on the tissue. This concept
known as mask rotation, i.e. a planned
sequential utilisation of different interfaces,
can reduce pressure effects by alternating the
points of highest pressure, and is also useful
to improve the tolerance and efficacy of NIV
[14]. The alternation of an oronasal mask and
a full-face mask allows regular pressure relief
of the nasal bridge. Other interfaces without
contact with the nasal bridge, for example
masks with a cut-out on the nasal bridge or
nasal prongs, can also be tried. In patients at
high risk of pressure ulcers, mask rotation
should be started from the beginning.
The routine use of additional protective
coverings applied to areas with the highest
pressure can reduce the occurrence of
pressure ulcers. Pads of foam [26], hydro-
colloids [32] or gel distribute the pressure,
reduce friction and can also reduce small air
leaks at the same time (fig. 4 and 5). They are
recommended for patients with a high risk of
pressure ulcers from the beginning of NIV or,
at the latest, from when the first signs of
redness appear on the skin. It is important
not to create more pressure on the skin when
the dressing is placed (fig. 6).
The helmet is the only interface that does
not create pressure ulcers on the face and is a
useful alternative for experienced centres, if
pressure effects on the face become a NIV-
limiting problem. However, it has to be kept
in mind that the use of a helmet can create
skin damage along the braces under the
armpits or around the neck. A case of arm
vein thrombosis due to pressure from the
attachment straps has been described in a
very cachectic patient [33].
Upper-airway obstruction
High pressure from the lower mask strap can
sometimes provoke or aggravate upper air-
way obstruction by pushing the lower jaw
backwards. This is normally not a problem
Figure 3
The two-finger rule: when the headgear is attached it
should be possible to pass two fingers beneath it [30].
Figure 4
Example for skin protection: a self-cut foam
(Mo¨lnlycke Health Care, Go¨teborg, Sweden) dressing
on a head model.
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when the mask is initially fitted in an upright
or semi-recumbent position, but might be
seen in some patients in the supine position
or during rapid eye movement sleep. The
obvious solution to this problem is to loosen
the straps, refit the mask or slightly increase
the expiratory positive airway pressure. When
a secure mask fit cannot be obtained without
higher strap tension, the addition of a stiff
neck collar or a rolled-up towel under the chin
can be considered to help keep the upper
airway open.
Skin
To reduce the risk of skin irritation it is
important to keep the skin and mask clean
and dry throughout the treatment. If redness,
rashes or blistering occur, a change to a
silicone and latex free mask cushion, applica-
tion of barrier cream and covering the
damaged skin to protect it when the mask
is in place can all be tried. If an allergic rash
occurs, the mask cushion should be changed
to a different material and application of
steroid cream can be considered.
Regular reassessment
Movements, sweating, change of fluid status
and the tendency of Velcro straps to loosen
gradually over time can change mask fit.
Thus, no matter how well the interface fits at
the start of NIV, it is important to routinely
monitor air leaks and skin condition and to
reassess mask fit throughout the treatment.
Dryness of mucosa and humidification
Oral and nasal dryness or a blocked nose are
frequent complaints during NIV with an
occurrence rate of 10–50% [1, 2, 34]. They
are indicative of air leaking through the
mouth or around the mask, but even without
an air leak, patients can be troubled by these
symptoms. Cold, dry air from the ventilator,
often caused by a higher oxygen fraction,
promotes the release of inflammatory medi-
ators in the nasal mucosa, increases mucosal
blood flow and thereby increases nasal airway
resistance and causes congestion. Treatment
options include the topical nasal application
of saline, hyaluronic acid, steroids, decon-
gestants or antihistamines, and regular mouth
care, as well as the addition of heat/moisture
exchangers and an external heated humidifier
to the circuit.
The use of active humidification of the
inspired gas is mandatory for patients with a
tracheostomy, but its use in NIV is not always
necessary. Nevertheless, it should be added
to the circuit with a low threshold, especially
if leaks are present or a high oxygen fraction
is delivered as it can attenuate the increase in
resistance in the nasal mucosa, decrease
dryness and enhance comfort and tolerance
of mask ventilation [35]. It is also recom-
mended to avoid thickened and tenacious
secretions. Gas temperatures during NIV do
not need to be as great as for intubated
patients and are to be based on patient
comfort (benchmark of 100% relative humidity
at about 30uC) [36]. Heat/moisture exchangers
Figure 5
Different self-cut hydrocolloid and gel sheets to be
placed between skin and mask. From left to right:
Kerra ProTM (Crawford Healthcare Ltd, Knutsford,
UK), Aderma (Smith & Nephew, London, UK) and
GeckoTM (ResMed Ltd.)
Figure 6
Foam and silicone sheets between mask and skin.
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cannot be unconditionally recommended for
NIV, because the additional dead space can
decrease CO2 elimination and increase the
work of breathing, which can become prob-
lematic, in particular in hypercapnic ARF or if
the delivered tidal volumes are very low [37].
Sedation
The topic of sedative medication to improve
tolerance of the NIV interface is still contro-
versial. The idea is to mitigate the patient’s
level of discomfort and obtain a level of
awake sedation without significant effects on
respiratory drive, minute volume, respiratory
pattern, blood gases, haemodynamics and
airway reflexes. The best way to improve
interface tolerance during NIV is still good
nursing and multidisciplinary care with
intensive psychological support and reassur-
ance of the patient. However, for some
patients who remain very anxious or agitated
with the mask, a small dose of an anxiolytic
may be appropriate. Many pulmonary and
critical care physicians in North America and
Europe are reluctant to use sedation because
of the perceived risks of interfering with the
ability to protect the airway or depressing
respiratory drive [38]. Nevertheless, careful
and mild sedation in selected patients in
ICUs with a high nurse to patient ratio and
special focus and attention on airway protec-
tion and consciousness is usually safe, and
can sometimes help to prevent NIV failure
due to low tolerance. The ability to use
sedatives or analgesics on wards with a lower
degree of monitoring is very limited and
cannot be recommended.
Acute-on-chronic
respiratory failure
The number of patients with chronic respir-
atory failure who are on long-term home NIV
is also constantly on the increase. These
patients are normally treated in specialised
centres, but during acute exacerbations may
present to the nearest emergency department
or ICU for initial treatment. They will often
bring their own mask and ventilator equip-
ment with them and, while it is usually
necessary to adjust the ventilator settings
during the exacerbation, their mask can
continue to be used. Although these patients
are ‘‘expert patients’’ concerning their mask
management and NIV, this does not imply
that they will not have mask problems in the
acute setting. Patients who are well adapted
to nasal masks or nasal prongs at home
might suddenly start mouth breathing during
the exacerbation, which will necessitate a
temporary switch to an oronasal mask or total
facemask. The risk for facial pressure ulcers
can increase in the context of a more severe
illness with, for example, worse oxygenation
or lower blood pressure. Increases in pres-
sure support can lead to air leaks and
consequently increased tightening of the
straps might follow. In addition, patients
may suddenly find themselves on NIV for
most of the 24-h period instead of only using
it at night, or be unable to correctly self-
manage the mask because of weakness.
These patients will have to be able to
continue the treatment after the exacerbation,
which can become very uncomfortable or
painful with a pressure sore on the face and
prolonged wound healing due to complicated
pressure relief. Patients on home NIV can
have the same mask problems as all other
patients in the acute setting and there is a
need for regular reassessment of mask fit,
skin underneath the mask and headgear, risk
factors for pressure ulcers and for precau-
tions to reduce the incidence of skin damage
or NIV failure.
Feeding tubes, beards and
other problems
NIV can be used with a nasogastric tube in
place and some masks incorporate a special
nasogastric tube adapter. If such a mask or a
separate nasogastric tube adapter is not
available, padding of the tube and the skin
underneath the tube with a silicone dressing
or other material is recommended to mini-
mise air leakage and pressure on the skin.
Regular reassessment of the skin under the
nasogastric tube, in particular in the area
where it is in contact with the mask frame,
should be carried out and the position of the
tube alternated if the treatment has to be
prolonged.
Another frequent problem mainly asso-
ciated with air leaks is beards. Shaving is a
very quick and effective solution to this
problem, but if this is inappropriate, an
oronasal mask is usually more effective with
Interface problems in acute noninvasive ventilation
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moustaches than nasal masks, and full
beards can sometimes be managed better
with nasal prongs, total face masks, or with
helmets in the ICU of an experienced centre.
Dentures can also become a problem, as
a mask that fits very well with the denture in
place might not fit once the denture is
removed at night. It is important to be aware
of this potential change in mask fit and to
have an alternative mask quickly available, if
needed.
For patients who are unable to raise their
arms to pull the mask over their head or to
reach the strap to remove the mask them-
selves because of weakness, neuromuscular
disease or severe arthritis, a quick-release
strap can be added.
Droplet generation and
airborne disease
NIV is a droplet-generating procedure, which
raises concerns about infection control and
staff protection with its use during outbreaks
of diseases, such as pandemic influenza
(H1N1) or severe acute respiratory syndrome,
or with airborne diseases such as tuber-
culosis. The amount of droplets falls signifi-
cantly at a distance .1 m from the patient
[39, 40], but healthcare workers who apply
NIV have to stand close to the patient and,
therefore, can be exposed to potentially
infectious droplets. The decision whether or
not NIV can be used in these situations, as
well as the general precautions to reduce
disease transmission, usually depends on
local infection policies. However, if NIV is
applied, a nonvented facial mask and filtered
exhalate can reduce environmental spread
[39]. Also, fitting and securing the mask
before the ventilator is turned on and
similarly turning off the ventilator before the
mask is removed or lifted away from the face
is usually recommended.
Conclusion
Skills in mask fitting and prevention of mask-
related problems are key components for NIV
success. Not all hospitals and NIV services
will be able to stock a large volume of
different masks, which makes routine risk
assessment for mask-related pressure ulcers,
and knowledge and strategic use of skin
protective strategies even more important.
Training programmes for NIV should impart
this knowledge and qualify the team to tailor
interface choice and preventive strategies to
each patient’s individual facial characteristics
and needs.
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Educational questions
1) Which of the following statements concerning mask choice is/are true?
a. Masks covering mouth and nose are more effective in improving blood gases than nasal
masks in acute respiratory failure
b. Oronasal masks are better tolerated and more comfortable than nasal masks in acute
respiratory failure
c. Oronasal masks are usually the first choice for NIV in acute respiratory failure in Europe
d. Mask switching is not recommended in the first 24 h of NIV in acute respiratory failure
2) Which of the following statements concerning interface-related pressure ulcers in NIV is/
are true?
a. Pressure ulcers occur more often with oronasal than nasal masks
b. A helmet cannot create pressure ulcers
c. The use of skin protective dressings can reduce the incidence of pressure ulcers
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Suggested
answers
1) a. false, b. false, c.
true, d. false
2) a. true, b. false, c.
true, d. false
3) c.
4) c.
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